Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cobalt Boats Wins Two Prestigious Neptune Awards for Marketing Excellence
-
BellRing Brands Announces New Share Repurchase Authorization of $300 Million
-
Sage brings expertise in data and insights to global sport via partnership with Sportable
-
BitFuFu Completes Business Combination with Arisz Acquisition Corp
-
Silvano Fashion Group Consolidated Interim Financial Report for Q4 and 12 months of 2023 (unaudited)
-
Arisz Acquisition Corp. Closes Its Business Combination with BitFuFu (Finfront Holding Company)
-
ARKO Corp. Announces Participation in Raymond James 45th Annual Institutional Investors Conference
-
Grupo Aeroportuario Del Pacifico Announces Annual General Ordinary And Extraordinary Shareholders’ Meeting
-
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
-
Euro Manganese Announces Results of Annual General and Special Meeting
-
Tarsus Announces Proposed $100.0 Million Public Offering
-
Toll Brothers Announces Beckham Place at Morningside Model Home Grand Opening in Atlanta Area
-
Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau
-
Bunker Hill Provides Project Restart Update February 2024
-
Latitude Uranium Announces Receipt of Final Order for Arrangement with ATHA
-
Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call
-
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
-
Reborn Coffee Closes $1.0 Million Private Placement Equity Investment from Accredited Investor
-
IDT Corporation to Report Second Quarter Fiscal 2024 Results
-
Tecnoglass Reports Record Financial Metrics Across the Board for Full Year 2023
-
Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
-
Aterian Sets Date for Fourth Quarter & Full Year 2023 Earnings Announcement & Investor Conference Call
-
Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results
-
Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
-
Sun Communities, Inc. to Present at the 2024 CITI Global Property CEO Conference
-
Badger Infrastructure Solutions Ltd. Announces Record 2023 Full Year Revenue and Adjusted EBITDA and a 4.3% Dividend Increase
-
Capital City Bank Group, Inc. Increases Cash Dividend
-
Parsons to Present at the Raymond James 45th Annual Institutional Investors Conference
-
FTAI Infrastructure Inc. Reports Fourth Quarter and Full Year 2023 Results, Declares Dividend of $0.03 per Share of Common Stock
-
Carestream Dental Cares for its Sensei Customers During Healthcare Partner Outage
-
Ross Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business Combination
-
Dr. K.L. Allen Named Regional Vice President, Northeast
-
Wintrust Financial Corporation to Present at Raymond James 45th Annual Institutional Investors Conference
-
CubeSmart Reports Fourth Quarter and Annual 2023 Results
-
Clarus Completes Sale of Precision Sport Segment to JDH Capital
-
P10 Reports Fourth Quarter and Full Year 2023 Earnings Results
-
Black Hills Corp. Announces Investor Meetings and Reaffirms Guidance
-
FG Financial Group, Inc. and FG Group Holdings Inc. Complete Merger
-
The RealReal Announces Fourth Quarter and Full Year 2023 Results
-
VALHI DECLARES QUARTERLY DIVIDEND
-
CooperCompanies Announces First Quarter 2024 Results
-
Kite Realty Group Trust to Present at the Citi 2024 Global Property CEO Conference
-
Montauk Renewables Schedules Full Year 2023 Conference Call for Thursday, March 14, 2024, at 5:00 p.m. ET
-
RadNet Reports Fourth Quarter 2023 Results, Including Record Revenue and Adjusted EBITDA(1), Releases 2024 Financial Guidance and Forms a New Digital Health Reporting Segment
-
Certara Reports Fourth Quarter 2023 Financial Results
-
GENFIT Announces Revenues and Cash Position as of December 31, 2023
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
-
Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock
-
Cardiff Oncology Provides Clinical Update on Phase 2 Randomized Second-line ONSEMBLE Trial in Patients with RAS-mutated mCRC
